Activity Provided By:

ACHL

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

Overview / Abstract:	Join the discussion! We bring the expert to you. LIVE. VIRTUAL. FLEXIBLE. Interactive discussion on optimization of RET+ testing in NSCLC and thyroid cancer, and the pathways for enhancing collaboration between pathologists and oncologists to improve patient care. Choose a date that works best with your schedule! Your questions answered on precision medicine! - What are the roles of biomarkers? - When should biomarker testing occur? - What do the test results mean? - How does the mutational burden impact treatment selection? - When should novel agents be selected? - How can pathologists help inform treatment decisions? - How can barriers to collaboration between pathologists and oncologists be overcome? - How can collaboration between pathologists and oncologists improve patient outcomes? Clinicians, be ready for the future and stay at the forefront of precision medicine in cancer care.
Expiration	May 31, 2022
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Live / Seminar
Credits / Hours	1.0
Accreditation	ACCME and ABPath Continuing Certification
Is This Activity Certified for "Live" Credit?	YES
Presenters / Authors / Faculty	Justin Gainor, MD (Chair) Associate Professor of Medicine at Harvard Medical School Director, Center for Thoracic Cancers Director of Targeted Immunotherapy Massachusetts General Hospital Boston, MA Laura Tafe, MD (Chair) Associate Professor of Pathology and Laboratory Medicine Geisel School of Medicine Assistant Director, Laboratory for Clinical Genomics and Advanced Technology (CGAT) Dartmouth-Hitchcock Medical Center Lebanon, NH Taofeek Owonikoko, MD, PhD (Faculty) Professor of Medicine, Division of Hematology-Oncology Division Chief, Division of Hematology-Oncology Stanley Marks / OHA Chair in Oncology Leadership Associate Director for Translational Research, UPMC Hillman Cancer Center Co-Leader, Cancer Therapeutics Program, UPMC Hillman Cancer Center Pittsburgh, PA Karen Reckamp, MD, MS (Faculty) Clinical Professor of Medicine Director, Division of Medical Oncology Medical Oncology Director, Women’s Guild Lung Institute Associate Director for Clinical Research, Cedars Sinai Cancer Cedars Sinai Medical Center Noah Brown, MD (Faculty) Associate Professor Director, Molecular Diagnostics Laboratory Department of Pathology and Clinical Labs University of Michigan Ann Arbor, MI
Activity Specialities / Related Topics	Oncology / Cancer / Radiation Therapy, Pathology
Sponsors / Supporters / Grant Providers	Sponsored by the Academy for Continued Healthcare Learning (ACHL) and Penn State College of Medicine. This activity is supported by an educational grant from Lilly and Genentech, Inc.
Keywords / Search Terms	ACHL CME/CE, CME, CE, Penn State University College of Medicine, RET+, NSCLC, Thyroid Cancer, Cancer, oncologists, pathologists, oncology, pathology, RET inhibition, tumor, non–small cell lung cancer, RET testing, solid tumor, biomarker testing, meet-up Free CE CME Live CE CME Seminar CE CME
LIVE Activity Location Details	Date(s) 11-16-2021 - 05-31-2022 Zoom link provided at registration N/A N/A N/A United States of America

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map